ARCHIVES

Advisors seek support for NCI’s “special authorities” granted in 1971.

This article is from The Cancer Letter archive.

Vol. 31 No. 28 | July 15, 2005

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Continuing Neutron Trials Pas 1989 Expiration, With New Funding Plan

June 10, 1988

In Brief: Three Patients Evaluated For Gene Therapy; Revised Program Instructions Available

November 30, 1990

Sloan-Kettering Sues Empire Blue Cross Over Reimbursement

September 17, 1993

Three Organizations Publish Guideline For Biomarker Testing for Targeted Therapies

April 26, 2013

William Nelson Named Cancer Center Director At Johns Hopkins.

November 7, 2008

FDA Approves Rituxan For CLL

February 19, 2010